Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

Clinical trial NCT01932372 · COMPLETED

Trial details

NCT number: NCT01932372
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Rheumatoid Arthritis

Start date: 2013-07-26
Primary completion: 2021-08-24
Enrollment: 9968

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.